PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,836 | +82.7% | 64,166 | +86.6% | 0.12% | +86.4% |
| Q1 2024 | $1,005 | -12.2% | 34,382 | +1.3% | 0.07% | -18.5% |
| Q4 2023 | $1,145 | +17.9% | 33,935 | +7.3% | 0.08% | +8.0% |
| Q3 2023 | $971 | +15.5% | 31,641 | +50.8% | 0.08% | +4.2% |
| Q2 2023 | $841 | +10.2% | 20,977 | +12.2% | 0.07% | 0.0% |
| Q1 2023 | $763 | +37.5% | 18,694 | +30.0% | 0.07% | +12.5% |
| Q4 2022 | $555 | -99.9% | 14,381 | +6.3% | 0.06% | -28.1% |
| Q3 2022 | $720,000 | -3.7% | 13,529 | +5.5% | 0.09% | 0.0% |
| Q2 2022 | $748,000 | -23.0% | 12,827 | +0.7% | 0.09% | -13.6% |
| Q1 2022 | $972,000 | +28.6% | 12,742 | +1.4% | 0.10% | +24.1% |
| Q4 2021 | $756,000 | +99.5% | 12,564 | +85.7% | 0.08% | +48.2% |
| Q3 2021 | $379,000 | – | 6,766 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 273,000 | $8,818,000 | 6.24% |
| Standard Investments LLC | 775,388 | $25,045,000 | 4.58% |
| ARMISTICE CAPITAL, LLC | 400,000 | $12,920,000 | 3.06% |
| HealthCor Management, L.P. | 1,575,000 | $50,873,000 | 2.88% |
| DARUMA CAPITAL MANAGEMENT LLC | 1,219,642 | $39,394,000 | 2.24% |
| Consonance Capital Management LP | 631,805 | $20,407,000 | 2.24% |
| Rock Springs Capital Management LP | 713,000 | $23,030,000 | 1.54% |
| Biondo Investment Advisors, LLC | 142,473 | $4,602,000 | 1.52% |
| Opus Point Partners Management, LLC | 50,000 | $1,615,000 | 1.29% |
| Partner Investment Management, L.P. | 26,690 | $862,000 | 1.14% |